Biotricity, Inc. - Condensed Consolidated Balance Sheets - USD ($)		Jun. 30, 2016	Dec. 31, 2015
CURRENT ASSETS
Cash		$ 33,898	$ 410,601
Harmonized sales tax recoverable		26,119	36,291
Deposits and other receivables		49,653	72,202
Total Assets		109,670	519,094
Current Liabilities:
Due to shareholders	[1]	11,632
Convertible promissory notes	[2]	612,592
Derivative liabilities	[3]	542,294
Accounts payable and accrued liabilities	[4]	611,382	413,273
Total current liabilities		1,777,901	413,273
Convertible promissory note	[2]	928,990	783,778
Derivative liabilities	[3]	1,072,452	561,220
TOTAL LIABILITIES		3,779,343	1,758,271
Stockholders' Deficiency:
Preferred stock	[5]	1	1
Common stock	[6]	25,000	25,000
Common stock to be issued	[7]	13
Additional paid-in capital		7,995,585	7,982,598
Accumulated other comprehensive loss		(147,785)	(18,002)
Accumulated deficit		(11,542,487)	(9,228,774)
TOTAL STOCKHOLDERS' DEFICIENCY		(3,669,673)	(1,239,177)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY		109,670	519,094
Commitments	[8]
Subsequent events	[9]
Going Concern	[10]

[1] See Note 5

[2] See Note 7

[3] See Note 8

[4] See Note 6

[5] $0.001 par value; 10,000,000 shares authorized at June 30, 2016 (December 31, 2015: 1,000,000), 1 share issued and outstanding as at June 30, 2016 and December 31, 2015, respectively. See Note 9

[6] $0.001 par value; 125,000,000 authorized as at June 30, 2016 (December 31, 2015: 100,000,000), 15,876,947 outstanding common shares as at June 30, 2016 and December 31, 2015 and 9,123,031 outstanding exchangeable shares as at June 30, 2016 and December 31, 2015. See Note 9

[7] See Note 9

[8] See Note 11

[9] See Note 12

[10] See Note 3